Policy Guidance on Drug-Susceptibility Testing (DST) of Second-Line Antituberculosis Drugs

Excerpt

This document is intended to provide an interim policy framework for the laboratory component relevant to programmatic implementation of MDR-TB strategies. A detailed technical manual on laboratory methodology, laboratory biosafety and standard operating procedures related to second-line drug-susceptibility testing (DST) is also under preparation.